Ohcanbohtosat - Pascal Lebray

Aiddostahte ozu
  1. 1
    Liver stiffness is an unreliable marker of liver fibrosis in patients with cardiac insufficiency

    Liver stiffness is an unreliable marker of liver fibrosis in patients with cardiac insufficiency Dahkki Pascal Lebray, Shaïda Varnous, Frédéric Charlotte, Anne Varaut, Thierry Poynard, Vlad Ratziu

    Almmustuhtton 2008
    Viečča ollesdeavstta
    Carta
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Natural history and predictors of disease severity in chronic hepatitis C

    Natural history and predictors of disease severity in chronic hepatitis C Dahkki Julien Massard, Vlad Ratziu, Dominique Thabut, J. Moussalli, Pascal Lebray, Yves Benhamou, Thierry Poynard

    Almmustuhtton 2005
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Late acute cellular rejection after switch to everolimus monotherapy at 11 months following liver transplantation

    Late acute cellular rejection after switch to everolimus monotherapy at 11 months following liver transplantation Dahkki Chantelli Iamblaudiot Razafindrazoto, Noémie Trystram, Gustavo Miranda Martins, Christiane Stern, Frédéric Charlotte, Pascal Lebray

    Almmustuhtton 2022
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Peptic ulcer bleeding in patients with or without cirrhosis: different diseases but the same prognosis?

    Peptic ulcer bleeding in patients with or without cirrhosis: different diseases but the same prognosis? Dahkki Marika Rudler, G. Rousseau, Hédi Benosman, Julien Massard, Lionel Deforges, Pascal Lebray, Thierry Poynard, Dominique Thabut

    Almmustuhtton 2012
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    1005 DOES LIVER IMPAIRMENT CORRELATE WITH EARLY MORTALITY IN HEART TRANSPLANT PATIENTS?

    1005 DOES LIVER IMPAIRMENT CORRELATE WITH EARLY MORTALITY IN HEART TRANSPLANT PATIENTS? Dahkki Pascal Lebray, S. Varnous, Alina Pascale, R Macrì, Charles‐Édouard Luyt, Daniel Eyraud, Vlad Ratziu, A Pavie

    Almmustuhtton 2013
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    Clinical validation of the FLIP algorithm and the SAF score in patients with non-alcoholic fatty liver disease

    Clinical validation of the FLIP algorithm and the SAF score in patients with non-alcoholic fatty liver disease Dahkki Fabio Nascimbeni, Pierre Bédossa, Larysa Fedchuk, Raluca Pais, Frédéric Charlotte, Pascal Lebray, Thierry Poynard, Vlad Ratziu

    Almmustuhtton 2019
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    NAFLD and liver transplantation: Current burden and expected challenges

    NAFLD and liver transplantation: Current burden and expected challenges Dahkki Raluca Pais, A. Sidney Barritt, Yvon Calmus, Olivier Scatton, Thomas M. Runge, Pascal Lebray, Thierry Poynard, Vlad Ratziu, Filoména Conti

    Almmustuhtton 2016
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    Progression of liver fibrosis in women infected with hepatitis C: Long-term benefit of estrogen exposure

    Progression of liver fibrosis in women infected with hepatitis C: Long-term benefit of estrogen exposure Dahkki Vincent Di Martino, Pascal Lebray, Robert P. Myers, E. Pannier, Valérie Paradis, Frédéric Charlotte, J. Moussalli, Dominique Thabut, Catherine Buffet, Thierry Poynard

    Almmustuhtton 2004
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  9. 9
    Screening for Liver Fibrosis by Using a Noninvasive Biomarker in Patients With Diabetes

    Screening for Liver Fibrosis by Using a Noninvasive Biomarker in Patients With Diabetes Dahkki Sophie Jacqueminet, Pascal Lebray, R. Morra, M. Munteanu, Laure Devers, Djamila Messous, Marine Bernard, Agnès Hartemann–Heurtier, Françoise Imbert‐Bismut, Vlad Ratziu

    Almmustuhtton 2008
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  10. 10
    Concordance in a World without a Gold Standard: A New Non-Invasive Methodology for Improving Accuracy of Fibrosis Markers

    Concordance in a World without a Gold Standard: A New Non-Invasive Methodology for Improving Accuracy of Fibrosis Markers Dahkki Thierry Poynard, Patrick Ingiliz, Laure Elkrief, M. Munteanu, Pascal Lebray, Rachel Morra, Djamila Messous, F. Imbert Bismut, Dominique Roulot, Yves Benhamou, Dominique Thabut, Vlad Ratziu

    Almmustuhtton 2008
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  11. 11
    A Prospective Analysis of the Prognostic Value of Biomarkers (FibroTest) in Patients with Chronic Hepatitis C

    A Prospective Analysis of the Prognostic Value of Biomarkers (FibroTest) in Patients with Chronic Hepatitis C Dahkki Yen Ngo, M. Munteanu, Djamila Messous, Frédéric Charlotte, Françoise Imbert‐Bismut, Dominique Thabut, Pascal Lebray, Vincent Thibault, Yves Benhamou, J. Moussalli, Vlad Ratziu, Thierry Poynard

    Almmustuhtton 2006
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  12. 12
    10 RESULTS OF A PROOF OF CONCEPT STUDY (C210) OF TELAPREVIR MONOTHERAPY AND IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 4 HCV PATIENTS

    10 RESULTS OF A PROOF OF CONCEPT STUDY (C210) OF TELAPREVIR MONOTHERAPY AND IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 4 HCV PATIENTS Dahkki Y. Benhamou, J. Moussalli, Vlad Ratziu, Pascal Lebray, V. Gysen, K. de Backer, A Ghys, Rolf van Heeswijk, Tony Vangeneugden, Gastón Picchio, Maria Beumont‐Mauviel

    Almmustuhtton 2009
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  13. 13
    An Accurate Definition of the Status of Inactive Hepatitis B Virus Carrier by a Combination of Biomarkers (FibroTest-ActiTest) and Viral Load

    An Accurate Definition of the Status of Inactive Hepatitis B Virus Carrier by a Combination of Biomarkers (FibroTest-ActiTest) and Viral Load Dahkki Yen Ngo, Yves Benhamou, Vincent Thibault, Patrick Ingiliz, M. Munteanu, Pascal Lebray, Dominique Thabut, Rachel Morra, Djamila Messous, Frédéric Charlotte, Françoise Imbert‐Bismut, Dominique Bonnefont–Rousselot, J. Moussalli, Vlad Ratziu, Thierry Poynard

    Almmustuhtton 2008
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  14. 14
    Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)

    Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest) Dahkki Thierry Poynard, Pascal Lebray, Patrick Ingiliz, Anne Varaut, B. Varsat, Yen Ngo, Pascal Norha, M. Munteanu, Fabienne Drane, Djamila Messous, F. Imbert Bismut, J.P. Carrau, Julien Massard, Vlad Ratziu, Jean Pierre Giordanella

    Almmustuhtton 2010
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  15. 15
    Long‐term prognostic value of the FibroTest in patients with non‐alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease

    Long‐term prognostic value of the FibroTest in patients with non‐alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease Dahkki M. Munteanu, Raluca Pais, Valentina Peta, Olivier Deckmyn, J. Moussalli, Yen Ngo, Marika Rudler, Pascal Lebray, Frédéric Charlotte, Vincent Thibault, Olivier Lucidarme, An Ngo, Françoise Imbert‐Bismut, Chantal Housset, Dominique Thabut, Vlad Ratziu, Thierry Poynard

    Almmustuhtton 2018
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  16. 16
    Ribavirin for Chronic Hepatitis E Virus Infection in Transplant Recipients

    Ribavirin for Chronic Hepatitis E Virus Infection in Transplant Recipients Dahkki Nassim Kamar, Jacques Izopet, Simona Tripon, Michaël Bismuth, Sophie Hillaire, Jérôme Dumortier, Sylvie Radenne, Audrey Coilly, Valérie Garrigue, Louis d’Altéroche, Matthias Büchler, Lionel Couzi, Pascal Lebray, Sébastien Dharancy, Anne Minello, Maryvonne Hourmant, Anne‐Marie Roque‐Afonso, Florence Abravanel, Stanislas Pol, Lionel Rostaing, Vincent Mallet

    Almmustuhtton 2014
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  17. 17
    Factors Associated With Chronic Hepatitis in Patients With Hepatitis E Virus Infection Who Have Received Solid Organ Transplants

    Factors Associated With Chronic Hepatitis in Patients With Hepatitis E Virus Infection Who Have Received Solid Organ Transplants Dahkki Nassim Kamar, Cyril Garrouste, Elizabeth B. Haagsma, Valérie Garrigue, Sven Pischke, Cécile Chauvet, Jérôme Dumortier, Amélie Cannesson, E. Cassuto‐Viguier, Éric Thervet, Filoména Conti, Pascal Lebray, Harry R. Dalton, Robert N. Santella, Nada Kanaan, Marie Essig, Christiane Mousson, Sylvie Radenne, Anne‐Marie Roque‐Afonso, Jacques Izopet, Lionel Rostaing

    Almmustuhtton 2011
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  18. 18
    Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programme

    Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programme Dahkki Christophe Hézode, Pascal Lebray, Victor de Lédinghen, Fabien Zoulim, Vincent Di Martino, Nathalie Boyer, Dominique Larrey, Danielle Botta‐Fridlund, Christine Silvain, Hélène Fontaine, Louis d’Altéroche, Vincent Leroy, Marc Bourlière, I. Hubert-Fouchard, Dominique Guyader, Isabelle Rosa, Éric Nguyen-Khac, Larysa Fedchuk, Raoudha Akremi, Y. Bennai, Anne Filipovics, Yue Zhao, Jean‐Pierre Bronowicki

    Almmustuhtton 2017
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  19. 19
    Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria

    Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria Dahkki Christophe Duvoux, Françoise Roudot‐Thoraval, Thomas Decaens, Fabienne Pessione, Hanaa Badran, Tullio Piardi, Claire Francoz, Philippe Compagnon, Claire Vanlemmens, Jérôme Dumortier, Sébastien Dharancy, Jean Gugenheim, Pierre–Henri Bernard, René Adam, Sylvie Radenne, Fabrice Muscari, Filoména Conti, Jean Hardwigsen, Georges‐Philippe Pageaux, Olivier Chazouillères, Ephrem Salamé, Marie‐Noëlle Hilleret, Pascal Lebray, Armand Abergel, Marilyne Debette‐Gratien, Michael D. Kluger, Ariane Mallat, Daniel Azoulay, Daniel Cherqui

    Almmustuhtton 2012
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  20. 20
    Diagnosis and management of hepatic encephalopathy: The French recommendations

    Diagnosis and management of hepatic encephalopathy: The French recommendations Dahkki Dominique Thabut, Charlotte Bouzbib, Lucy Meunier, Manon Haas, Nicolas Weiss, Alexandre Louvet, F. Imbert-Bismut, Fanny Mochel, Yann Nadjar, Antoine Santiago, Thierry Thévenot, Véronique Duhalde, Frédéric Oberti, Claire Francoz, Audrey Coilly, Marie‐Noëlle Hilleret, Pascal Lebray, Amélie Liou‐Schischmanoff, Louise Barbier, Christophe Duvoux, Georges‐Philippe Pageaux, Michaël Bismuth, Damien Galanaud, T. de Broucker, Jean–François Cadranel, Vincent Leroy, Vincent Di Martino, Dominique Larrey, Christophe Camus, Olivier Scatton, Victor de Lédinghen, Ariane Mallat, Marika Rudler, Christophe Bureau

    Almmustuhtton 2023
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: